
    
      This study is designed to evaluate the analgesic efficacy of TRV130 for the treatment of
      moderate to severe acute pain associated with a long bone fracture in patients presenting to
      the ED. The safety and tolerability of TRV130 will also be evaluated in this open-label pilot
      study.
    
  